Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening

Surveillance for Onchocerciasis-Associated Epilepsy and OV16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening

To eliminate onchocerciasis-associated morbidity, it is important to identify areas where there is still high ongoing <i>Onchocerca volvulus</i> transmission. Between 2015 and 2021, door-to-door surveys were conducted in onchocerciasis-endemic villages in Cameroon, the Democratic Republi...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Alfred Dusabimana, Joseph Nelson Siewe Fodjo, Michel Mandro Ndahura, Bruno P. Mmbando, Stephen Raimon Jada, Annelies Boven, Eric De Smet, Tony Ukety, Alfred K. Njamnshi, Anne Laudisoit, Steven Abrams, Robert Colebunders
Format:	Article
Sprog:	English
Udgivet:	MDPI AG 2022-02-01
Serier:	Pathogens
Fag:	onchocerciasis onchocerciasis-associated epilepsy epilepsy prevalence incidence ivermectin OV16 antibodies
Online adgang:	https://www.mdpi.com/2076-0817/11/3/281

Lignende værker

OV16 Seroprevalence among Persons with Epilepsy in Onchocerciasis Endemic Regions: A Multi-Country Study
af: Alfred Dusabimana, et al.
Udgivet: (2020-10-01)

Epidemiology of epilepsy in Wulu County, an onchocerciasis-endemic area in South Sudan
af: Joseph Nelson Siewe Fodjo, et al.
Udgivet: (2024-09-01)

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
af: Joseph N. F. Siewe, et al.
Udgivet: (2019-01-01)

Single versus Multiple Dose Ivermectin Regimen in Onchocerciasis-Infected Persons with Epilepsy Treated with Phenobarbital: A Randomized Clinical Trial in the Democratic Republic of Congo
af: Michel Mandro, et al.
Udgivet: (2020-03-01)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
af: Robert Colebunders, et al.
Udgivet: (2019-10-01)

Effect of Ivermectin Treatment on the Frequency of Seizures in Persons with Epilepsy Infected with <i>Onchocerca volvulus</i>
af: Alfred Dusabimana, et al.
Udgivet: (2020-12-01)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
af: Joseph Nelson Siewe Fodjo, et al.
Udgivet: (2018-12-01)

Comprehensive management of epilepsy in onchocerciasis-endemic areas: lessons learnt from community-based surveys
af: Joseph Nelson Siewe Fodjo, et al.
Udgivet: (2019-02-01)

Prevalence and incidence of nodding syndrome and other forms of epilepsy in onchocerciasis-endemic areas in northern Uganda after the implementation of onchocerciasis control measures
af: Nolbert Gumisiriza, et al.
Udgivet: (2020-03-01)

Reducing onchocerciasis-associated morbidity in onchocerciasis-endemic foci with high ongoing transmission: a focus on the children.
af: Robert Colebunders, et al.
Udgivet: (2022-03-01)

Focus of Ongoing Onchocerciasis Transmission Close to Bangui, Central African Republic
af: Eric de Smet, et al.
Udgivet: (2020-04-01)

Epilepsy in the onchocerciasis endemic area of Deim Zubeir, South Sudan: a household survey
af: Jurel Payii Mamur, et al.
Udgivet: (2025-02-01)

Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed
af: Robert Colebunders, et al.
Udgivet: (2024-01-01)

The Spectrum of Ocular Diseases in the Onchocerciasis-Endemic Focus of Raga in South Sudan
af: Sube KL, et al.
Udgivet: (2024-12-01)

The Prevalence of Onchocerciasis-Associated Epilepsy in Mundri West and East Counties, South Sudan: A Door-to-Door Survey
af: Stephen Raimon Jada, et al.
Udgivet: (2022-03-01)

Integration of onchocerciasis morbidity management and disability prevention services in the healthcare system in Tanzania: a call for action and recommendations
af: Vivian Mushi, et al.
Udgivet: (2024-01-01)

High Prevalence of Epilepsy in an Onchocerciasis-Endemic Area in Mvolo County, South Sudan: A Door-To-Door Survey
af: Stephen Raimon, et al.
Udgivet: (2021-05-01)

Ivermectin Treatment Response in Onchocerca Volvulus Infected Persons with Epilepsy: A Three-Country Short Cohort Study
af: Alfred Dusabimana, et al.
Udgivet: (2020-07-01)

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
af: Charlotte Boullé, et al.
Udgivet: (2019-03-01)

Stigma and epilepsy in onchocerciasis-endemic regions in Africa: a review and recommendations from the onchocerciasis-associated epilepsy working group
af: Sarah O’Neill, et al.
Udgivet: (2019-05-01)

Serotonin Levels in the Serum of Persons with Onchocerciasis-Associated Epilepsy: A Case-Control Study
af: Melissa Krizia Vieri, et al.
Udgivet: (2021-06-01)

High prevalence of epilepsy in onchocerciasis endemic health areas in Democratic Republic of the Congo
af: Evy Lenaerts, et al.
Udgivet: (2018-08-01)

Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo
af: Housseini Dolo, et al.
Udgivet: (2018-12-01)

Ivermectin as a promising therapeutic option for onchocerciasis‐associated epilepsy
af: Mohammad Amin Manavi, et al.
Udgivet: (2025-02-01)

No Evidence for the Involvement of Leiomodin-1 Antibodies in the Pathogenesis of Onchocerciasis-Associated Epilepsy
af: An Hotterbeekx, et al.
Udgivet: (2021-07-01)

Outstanding insecurities concerning the use of an Ov16-based ELISA in the Amazonia onchocerciasis focus
af: Sérgio Luiz Bessa Luz, et al.
Udgivet: (2014-07-01)

Immunoinformatics Design and Assessment of a Multiepitope Antigen (OvMCBL02) for Onchocerciasis Diagnosis and Monitoring
af: Bernis Neneyoh Yengo, et al.
Udgivet: (2022-06-01)

Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective
af: Ed Cupp, et al.
Udgivet: (2019-07-01)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
af: Joseph Nelson Siewe Fodjo, et al.
Udgivet: (2019-08-01)

Cytokines and Onchocerciasis-Associated Epilepsy, a Pilot Study and Review of the Literature
af: Melissa Krizia Vieri, et al.
Udgivet: (2021-03-01)

Ivermectin: Difficulties in resolving pharmacokinetic and pharmacodynamic relationships in onchocerciasis
af: E N Shu, et al.
Udgivet: (2004-01-01)

Impact assessment of onchocerciasis through lymphatic filariasis transmission assessment surveys using Ov-16 rapid diagnostic tests in Sierra Leone
af: Ibrahim Kargbo-Labour, et al.
Udgivet: (2024-03-01)

Onchocerciasis then and now: achievements, priorities and challenges
af: Adrian Hopkins
Udgivet: (2018-01-01)

The Role of the Maridi Dam in Causing an Onchocerciasis-Associated Epilepsy Epidemic in Maridi, South Sudan: An Epidemiological, Sociological, and Entomological Study
af: T. L. Lakwo, et al.
Udgivet: (2020-04-01)

Seroprevalence of onchocerciasis in Ogun State, Nigeria after ten years of mass drug administration with ivermectin
af: O. A. Surakat, et al.
Udgivet: (2018-09-01)

Report of the first international workshop on onchocerciasis-associated epilepsy
af: Robert Colebunders, et al.
Udgivet: (2018-03-01)

Onchocerciasis-associated epilepsy: an explorative case-control study with viral metagenomic analyses on Onchocerca volvulus [version 2; peer review: 2 approved]
af: Robert Colebunders, et al.
Udgivet: (2023-12-01)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
af: Kenneth Bentum Otabil, et al.
Udgivet: (2023-08-01)

Onchocerciasis: the beginning of the end?
af: Adrian Hopkins
Udgivet: (2019-02-01)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
af: M. Winnen, et al.